Informazioni sul prodotto
- Disodium (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-17-(2-hydroxyacetyl) -10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclo penta[a]phenanthrene-11,17-diolate
Betamethasone sodium is a long-acting corticosteroid that can be administered as a controlled-release preparation. It has been shown to inhibit the production of proinflammatory cytokines in skin cancer and reduces inflammation and irritation when applied topically. Betamethasone sodium is also used in ionotropic gelation, which is an analytical method for measuring the release of betamethasone from a hydrogel matrix. The procedure involves the measurement of changes in electrical impedance, which are related to the release of the drug from the hydrogel.